The constitutive activation of receptor tyrosine kinases (RTKs) such as ALK, MET, and VEGFR is known to promote tumor progression in ARMS, by reprogramming many intracellular pathways, such as those involved in differentiation [34]. Here, MET is linked to alveolar rhabdomyosarcoma.